Literature DB >> 2527348

Steroid secretion by a virilizing lipoid cell ovarian tumor: origins of dehydroepiandrosterone sulfate.

Y Shenker1, S N Malozowski, J Ayers, R J Grekin, A L Barkan.   

Abstract

A 78-year-old woman had a 3-year history of severe virilization caused by a lipoid cell ovarian tumor localized by pelvic ultrasound examination and NP-59 scan. Steroid secretion was evaluated by the following: 1) peripheral plasma levels before and after hormonal stimulation with ACTH or hCG, 2) venous catheterization and measurement of steroid levels in the left and right ovarian veins during surgery, 3) measurements of enzymatic activities in the tumor tissue compared with those in normal ovarian tissue, and 4) steroid secretion studies in vitro of the tumor tissue, surrounding tissue, and contralateral ovarian tissue. The tumor tissue secreted both delta 5 and delta 4 androgens, including dehydroepiandrosterone sulfate. Dehydroepiandrosterone sulfate was also secreted by the surrounding and contralateral ovarian tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527348

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Female Progressive Scalp Hair Loss Associated with Ovarian Thecoma.

Authors:  Andreia Munck; Andressa Sato de Aquino Lopes; Alessandra Anzai; Carolina Oliveira Costa Fechine; Neusa Yuriko Sakai Valente; Ricardo Romiti
Journal:  Skin Appendage Disord       Date:  2019-03-06

2.  A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor.

Authors:  André M Faria; Ricardo V Perez; José A M Marcondes; Daniel S Freire; Roberto Blasbalg; José Soares; Kleber Simões; Sylvia A Y Hayashida; Maria A A Pereira
Journal:  Nat Rev Endocrinol       Date:  2011-02-15       Impact factor: 43.330

3.  Ovarian thecoma with virilizing manifestations.

Authors:  Mun-Hwi Lee; Young-Jin Moon; Chang-Won Ha; Jeong-Kyu Hoh
Journal:  Yonsei Med J       Date:  2009-02-24       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.